Blonder Tongue Laboratories, Inc. (BDRL)

BDRL Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	0.08	0.27	0.07	0.57	0.56
Cash & Cash Equivalents	0.08	0.27	0.07	0.57	0.56
Cash Growth	-71.17%	297.10%	-87.94%	2.33%	232.74%
Receivables	3.39	1.77	1.74	2.51	2.65
Inventory	3.97	4.85	4.06	8.48	6.72
Other Current Assets	0.53	0.79	0.23	0.61	0.44
Total Current Assets	7.97	7.68	6.1	12.17	10.38
Property, Plant & Equipment	5.02	2.27	2.84	3.56	2.89
Goodwill and Intangibles	1.24	1.26	1.43	1.61	1.77
Other Long-Term Assets	0.79	0.7	0.76	1	0.56
Total Long-Term Assets	7.04	4.23	5.03	6.17	5.22
Total Assets	15.01	11.91	11.13	18.35	15.6
Accounts Payable	2.43	2.26	2.01	4.31	1.52
Current Debt	5.03	3.3	2.97	3.49	5.68
Other Current Liabilities	0.7	0.5	0.55	0.57	1.06
Total Current Liabilities	8.16	6.06	5.53	8.37	8.26
Long-Term Debt	5.78	2.57	4.36	2.62	0.17
Total Long-Term Liabilities	5.78	2.57	4.36	2.62	0.17
Total Liabilities	13.93	8.63	9.89	10.98	8.43
Total Debt	10.8	5.86	7.33	6.1	5.85
Debt Growth	84.27%	-19.98%	20.02%	4.36%	-9.37%
Retained Earnings	-30.23	-27.31	-27.39	-19.92	-19.18
Comprehensive Income	-0.98	-0.93	-0.95	-0.89	-0.83
Shareholders' Equity	1.07	3.29	1.24	7.36	7.17
Net Cash / Debt	-10.72	-5.59	-7.26	-5.53	-5.29
Net Cash Per Share	-0.81	-0.36	-0.73	-0.58	-0.59
Working Capital	-0.19	1.62	0.57	3.81	2.11
Book Value Per Share	0.08	0.27	0.13	0.77	0.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).